FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
18 letters match. Newest first.
-
DevicesCue Health, Inc.
FDA warned Cue Health that it changed its authorized COVID-19 tests without approval and released lots under a weak sampling plan.
High risk -
DevicesNorth American Diagnostics, LLC
FDA warns North American Diagnostics over unapproved COVID-19 antigen tests and quality system failures.
High risk -
DevicesEmpowered Diagnostics LLC
Empowered Diagnostics distributed COVID-19 test kits without FDA approval or emergency authorization, and some labeling falsely said they were authorized.
High risk -
DevicesUSA Medical LLC
FDA: USA Medical sold unapproved COVID-19 antigen tests with false EUA claims and lacked basic quality system procedures.
High risk -
DevicesW.H.P.M, Inc.
W.H.P.M. sold unapproved COVID-19 test kits in the U.S. and had quality-system violations.
High risk -
DevicesLusys Laboratories, Inc.
FDA warned Lusys Laboratories for selling two unapproved COVID-19 test kits in the U.S. without FDA clearance or authorization.
High risk -
DevicesDermaCare Biosciences, LTD.
DermaCare sold an unapproved, misbranded Easy Rapid Now COVID-19 antigen test directly to U.S. consumers, FDA says.
High risk -
DevicesLepu Medical Technology -Beijing- Co., Ltd.
FDA warns Lepu Medical Technology Beijing that its unapproved COVID-19 test kits are adulterated and misbranded.
High risk -
DevicesBiopolygen Corp.
FDA warned Biopolygen Corp. for selling three unapproved COVID-19 self-test kits directly to consumers online.
High risk -
DevicesUSH Diagnostics, Inc./covidinstanttest.net
USH Diagnostics/covidinstanttest.net offered unapproved at-home COVID-19 test kits with misleading FDA authorization claims.
High risk -
DevicesInnova Medical Group, Inc.
Innova Medical Group distributed unapproved COVID-19 antigen tests and had quality-system and labeling violations, FDA says.
High risk -
DevicesBaltimore Beauty Security Square Mall
Baltimore Beauty offered GenBody COVID-19 test kits directly to consumers without FDA approval, clearance, or authorization.
High risk -
DevicesSethi Laboratories
FDA warned Sethi Laboratories for selling unapproved COVID-19 antibody and antigen self-test kits directly to consumers and falsely claiming FDA authorization.
High risk -
DevicesFast Masks USA LLC
Fast Masks USA sold unapproved at-home COVID-19 test kits and claimed they were FDA approved or authorized, FDA says.
High risk -
DevicesIkcon Investments, Inc dba Ikcon Medical
FDA warned Ikcon Medical that it sold unapproved COVID-19 antibody and antigen tests online and made misleading 'FDA registered' claims.
High risk -
DevicesTresmonet Technologies, Inc., TM Testing, Inc. dba TM Technologies, Inc./TM Labs
FDA warned Tresmonet/TM Labs over selling an unapproved, misbranded at-home COVID-19 antibody test and claiming FDA approval.
High risk -
DevicesBlock Scientific
Block Scientific sold two COVID-19 antibody and antigen rapid tests online without FDA approval, clearance, or authorization.
High risk -
DevicesOrvic dba Webstore-USA
Orvic dba Webstore-USA sold an unapproved at-home COVID-19 antibody test online without FDA clearance, making it adulterated and misbranded.
High risk